Canada Pension Plan Investment Board Trevi Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

  • $98.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$2.36 - $3.55 $35,400 - $53,250
-15,000 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$2.42 - $3.99 $36,300 - $59,850
15,000 New
15,000 $36,000
Q3 2020

Nov 12, 2020
SELL
$3.5 - $7.62 $140,000 - $304,800
-40,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$2.51 - $6.87 $100,399 - $274,800
40,000 New
40,000 $263,000

Others Institutions Holding TRVI

# of Institutions
94
Shares Held
57.1M
Call Options Held
136K
Put Options Held
5.4K
View Full List

About Trevi Therapeutics, Inc.

TRVI Quotes by TradingView
  • Ticker TRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,322,500
  • Market Cap $164M
  • Description
  • Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...
More about TRVI
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email